The bill (LB168) from Sen. Brian Hardin of Gering would prohibit drugmakers from restricting the sale of medications included in the 340B program.

Legislative Bill 168, advanced 41-0, would forbid drugmakers taking part in Medicaid from denying or hindering eligible ...

The pharmaceutical industry and Colorado's hospitals agree that a federal program intended to reduce the cost of outpatient ...

Since 2020, six of eight community health centers in Rhode Island have seen their revenue from the 340B Drug Discount Program ...

The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to ...

It should always raise an eyebrow when someone tells you something is “free.” Free typically means there’s a catch or that ...

The AHA Feb. 28 filed a friend-of-the-court brief ( in the U.S. District Court for the District of Columbia, urging the court ...

Patients are paying the price — literally — for a loophole reducing health care competition in Colorado. Established more ...

The 340B program requires pharmaceutical companies to sell drugs at a discount to certain health care organizations.

Health care in Colorado is at a crisis. Democrats and Republicans fortunately have reached across party lines to solve ...

Four healthcare groups have filed an amicus brief in opposition to Johnson & Johnson's 340B rebate model, arguing the policy undermines federal law and threatens safety-net hospitals.

The proposed Oklahoma law would send more money to hospitals and chain pharmacies, not help Oklahomans, especially in rural ...